Hims & Hers Health Inc (NYSE:HIMS) shares traded -2.54% lower at $23.75 on Wall Street last session.
HIMS stock price is now 52.68% away from the 50-day moving average and 123.43% away from the 200-day moving average. The market capitalization of the company currently stands at $5.10B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $16 to $20, Citigroup Downgraded its rating from Buy to Neutral for Hims & Hers Health Inc (NYSE: HIMS). On April 16, 2024, Jefferies Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock reducing its target price from $17 to quote $15, while ‘Canaccord Genuity’ rates the stock as ‘Buy’
In other news, Chi Michael, Chief Commercial Officer sold 374,669 shares of the company’s stock on Jun 11 ’24. The stock was sold for $8,262,501 at an average price of $22.05. Upon completion of the transaction, the Chief Commercial Officer now directly owns 176,672 shares in the company, valued at $4.2 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 11 ’24, Chief Legal Officer Boughton Soleil sold 2,510 shares of the business’s stock. A total of $53,890 was realized by selling the stock at an average price of $21.47. This leaves the insider owning 154,345 shares of the company worth $3.67 million. A total of 29.74% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $5.65 and a high of $24.56. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 2.80, and a quick ratio of 2.48. The fifty day moving average price for HIMS is $15.7372 and a two-hundred day moving average price translates $10.71375 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for 2024-03-31. The net profit margin was -0.25% and return on equity was -0.72% for HIMS. The company reported revenue of $278.17 million for the quarter, compared to $190.77 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 45.81 percent.
